Vera Therapeutics, Inc.

Vera Therapeutics is a commercial-stage biotechnology company pursuing truth in science to transform medicine for autoimmune diseases, beginning with kidney conditions. The company focuses on upstream immune pathways and is deeply focused on IgA nephropathy, seeking to address unmet patient needs and develop transformative treatments that can reduce disease burden, including the need for dialysis or transplant. Vera was founded in 2016 and is headquartered in Brisbane, California.